Medifie: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medifie
Largest movements
- Cash +€79,556
up €79,556 (+70.3%), from €113,104 to €192,661
mainly Net result for the year (+€100,184) and Deferred charges and accrued income (+€4,769)
- Current investments +€10,500
new in 2025: €10,500
- Tangible fixed assets +€8,879
new in 2025: €8,879
- Deferred charges and accrued income -€4,769
down €4,769 (-34.0%), from €14,031 to €9,262
- Receivables within one year +€2,482
new in 2025: €2,482
- Reserves +€100,184
up €100,184 (+83.1%), from €120,560 to €220,744
- Tax, wage and social debts -€3,538
down €3,538 (-96.8%), from €3,656 to €118
of which Taxes: -€3,419
- Gross operating margin -€3,985
down €3,985 (-3.0%), from €132,208 to €128,223
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €127,136 | €223,784 | +€96,648 | +76.0% |
| Fixed assets | 21/28 | - | €8,879 | +€8,879 | |
| Tangible fixed assets | 22/27 | - | €8,879 | +€8,879 | |
| Furniture and vehicles | 24 | - | €8,879 | +€8,879 | |
| Current assets | 29/58 | €127,136 | €214,905 | +€87,769 | +69.0% |
| Amounts receivable within one year | 40/41 | - | €2,482 | +€2,482 | |
| Other amounts receivable | 41 | - | €2,482 | +€2,482 | |
| Current investments | 50/53 | - | €10,500 | +€10,500 | |
| Cash at bank and in hand | 54/58 | €113,104 | €192,661 | +€79,556 | +70.3% |
| Deferred charges and accrued income | 490/1 | €14,031 | €9,262 | -€4,769 | -34.0% |
| Total equity and liabilities | 10/49 | €127,136 | €223,784 | +€96,648 | +76.0% |
| Equity | 10/15 | €122,560 | €222,744 | +€100,184 | +81.7% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €120,560 | €220,744 | +€100,184 | +83.1% |
| Distributable reserves | 133 | €120,560 | €220,744 | +€100,184 | +83.1% |
| Amounts payable | 17/49 | €4,576 | €1,040 | -€3,536 | -77.3% |
| Amounts payable within one year | 42/48 | €4,576 | €1,040 | -€3,536 | -77.3% |
| Trade debts | 44 | €920 | €922 | +€3 | +0.3% |
| Suppliers | 440/4 | €920 | €922 | +€3 | +0.3% |
| Taxes, remuneration and social security | 45 | €3,656 | €118 | -€3,538 | -96.8% |
| Taxes | 450/3 | €3,419 | - | -€3,419 | |
| Remuneration and social security | 454/9 | €238 | €118 | -€120 | -50.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €657 | +€657 | |
| Other operating charges | 640/8 | €118 | €120 | +€2 | +1.7% |
| Gross operating margin | 9900 | €132,208 | €128,223 | -€3,985 | -3.0% |
| Operating profit (loss) | 9901 | €132,090 | €127,446 | -€4,644 | -3.5% |
| Financial income | 75/76B | - | €496 | +€496 | |
| Recurring financial income | 75 | - | €496 | +€496 | |
| Financial charges | 65/66B | €229 | €240 | +€12 | +5.1% |
| Recurring financial charges | 65 | €229 | €240 | +€12 | +5.1% |
| Profit (loss) for the period before taxes | 9903 | €131,862 | €127,701 | -€4,160 | -3.2% |
| Income taxes | 67/77 | €28,419 | €27,518 | -€901 | -3.2% |
| Profit (loss) for the period | 9904 | €103,443 | €100,184 | -€3,259 | -3.2% |
| Profit (loss) for the period to be appropriated | 9905 | €103,443 | €100,184 | -€3,259 | -3.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.